Cargando…

A systematic assessment of chemical, genetic, and epigenetic factors influencing the activity of anticancer drug KP1019 (FFC14A)

KP1019 ([trans-RuCl(4)(1H-indazole)(2)]; FFC14A) is one of the promising ruthenium-based anticancer drugs undergoing clinical trials. Despite the pre-clinical and clinical success of KP1019, the mode of action and various factors capable of modulating its effects are largely unknown. Here, we used t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golla, Upendarrao, Swagatika, Swati, Chauhan, Sakshi, Tomar, Raghuvir Singh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716741/ https://www.ncbi.nlm.nih.gov/pubmed/29228701 http://dx.doi.org/10.18632/oncotarget.21416

Ejemplares similares

Combined Transcriptomics and Chemical-Genetics Reveal Molecular Mode of Action of Valproic acid, an Anticancer Molecule using Budding Yeast Model
por: Golla, Upendarrao, et al.
Publicado: (2016)

DMSO reduces the cytotoxicity of anticancer ruthenium complex KP1019 in yeast
por: Davis, Jonathan, et al.
Publicado: (2021)

Sen1p Contributes to Genomic Integrity by Regulating Expression of Ribonucleotide Reductase 1 (RNR1) in Saccharomyces cerevisiae
por: Golla, Upendarrao, et al.
Publicado: (2013)

Ebselen induces reactive oxygen species (ROS)-mediated cytotoxicity in Saccharomyces cerevisiae with inhibition of glutamate dehydrogenase being a target()
por: Azad, Gajendra Kumar, et al.
Publicado: (2014)

Depletion of Cellular Iron by Curcumin Leads to Alteration in Histone Acetylation and Degradation of Sml1p in Saccharomyces cerevisiae
por: Azad, Gajendra Kumar, et al.
Publicado: (2013)

Correction: Depletion of Cellular Iron by Curcumin Leads to Alteration in Histone Acetylation and Degradation of Sml1p in Saccharomyces cerevisiae
por: Azad, Gajendra Kumar, et al.
Publicado: (2013)

Cantharidin downregulates PSD1 expression and inhibits autophagic flux in yeast cells
por: Swagatika, Swati, et al.
Publicado: (2022)

Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and Invasion
por: Bergamo, A., et al.
Publicado: (2009)

Investigation of the acetic acid stress response in Saccharomyces cerevisiae with mutated H3 residues
por: Saha, Nitu, et al.
Publicado: (2023)

NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
por: Alessio, Enzo, et al.
Publicado: (2019)

DNA Damage Response Checkpoint Activation Drives KP1019 Dependent Pre-Anaphase Cell Cycle Delay in S. cerevisiae
por: Bierle, Lindsey A., et al.
Publicado: (2015)

Testing Implementation of FFC-AL-EIT
por: Resnick, Barbara, et al.
Publicado: (2021)

Correction: DNA Damage Response Checkpoint Activation Drives KP1019 Dependent Pre-Anaphase Cell Cycle Delay in S. cerevisiae
Publicado: (2015)

The Impact of FFC-AL-EIT on Resident and Setting Outcomes
por: Boltz, Marie
Publicado: (2021)

En Route to Osmium Analogues of KP1019: Synthesis, Structure, Spectroscopic Properties and Antiproliferative Activity of trans-[Os(IV)Cl(4)(Hazole)(2)]
por: Büchel, Gabriel E., et al.
Publicado: (2011)

Interactions of molten salts with cathode products in the FFC Cambridge Process
por: Chen, George Z.
Publicado: (2020)

The Effectiveness of FFC-AL-EIT on Psychosocial Outcomes and Care Interactions
por: Galik, Elizabeth
Publicado: (2021)

X-ray Absorption Near Edge Structure Spectroscopy to Resolve the in Vivo Chemistry of the Redox-Active Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019)
por: Hummer, Alfred A., et al.
Publicado: (2013)

The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo()
por: Heffeter, Petra, et al.
Publicado: (2013)

MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate
por: Abdelfatah, Sara, et al.
Publicado: (2019)

PROCEEDINGS OF THE 17(th)ITALIAN CONVENTION OF FFC INVESTIGATORS IN CYSTIC FIBROSIS: VERONA 14(th)-16(th) NOVEMBER 2019 Every year, the Italian Cystic Fibrosis Research Foundation (FFC) brings together all its funded researchers from across Italy and beyond, in a Convention where results from FFC projects are shared and debated. These projects are either newly funded, on-going or recently concluded research. The Proceedings of the 17th Italian Convention of FFC Investigators in Cystic Fibrosis report the results of the concluded research projects. Correspondence: Dr. F. Malvezzi (flaminia.malvezzi@fibrosicisticaricerca.it)
Publicado: (2020)

Evaluation of Antioxidant and DNA Damage Protection Activity of the Hydroalcoholic Extract of Desmostachya bipinnata L. Stapf
por: Golla, Upendarrao, et al.
Publicado: (2014)

Can ultrasound elastography identify mass-like focal fatty change (FFC) from liver mass?
por: Qiu, Tingting, et al.
Publicado: (2017)

X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism
por: Bijelic, Aleksandar, et al.
Publicado: (2016)

The prognostic value of preoperative fibrinogen-to-prealbumin ratio and a novel FFC score in patients with resectable gastric cancer
por: Tang, Shuli, et al.
Publicado: (2020)

Feasibility of a Generic FFC Intervention for Long-Term Care: Evidence From Interventions in Various Care Settings
por: Vluggen, Stan, et al.
Publicado: (2021)

Characterization of Anticancer Effects of the Analogs of DJ4, a Novel Selective Inhibitor of ROCK and MRCK Kinases
por: Kale, Vijay Pralhad, et al.
Publicado: (2023)

Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo
por: d'Anglemont de Tassigny, Xavier, et al.
Publicado: (2017)

Obituary – Dr. KP Srivastava
por: Pruthi, KK
Publicado: (2017)

Asthma diagnosis and treatment – 1019. Churg Strauss Syndrome – missed diagnosis and consequences
por: Kamdar, Mahomed Cassim
Publicado: (2013)

PReS-FINAL-1019: Inflammatory monocytes induce resistance of effector t cells to suppression
por: Wehrens, EJ, et al.
Publicado: (2013)

The functional −1019C/G HTR1A polymorphism and mechanisms of fear
por: Straube, B, et al.
Publicado: (2014)

1019. The Future is Embedded in the Present - Characterizing Pharmacist Interventions in an Infectious Diseases Clinic
por: Depcinski, Shawn, et al.
Publicado: (2022)

Correction: Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo
por: d’Anglemont de Tassigny, Xavier, et al.
Publicado: (2018)

Copper inhibits protein maturation in the secretory pathway by targeting the Sec61 translocon in Saccharomyces cerevisiae
por: Saha, Nitu, et al.
Publicado: (2022)

Compliance of Clinical Trial Protocols for Foods with Function Claims (FFC) in Japan: Consistency between Clinical Trial Registrations and Published Reports
por: Kamioka, Hiroharu, et al.
Publicado: (2021)

Intracellular Water Lifetime as a Tumor Biomarker to Monitor Doxorubicin Treatment via FFC-Relaxometry in a Breast Cancer Model
por: Ruggiero, Maria Rosaria, et al.
Publicado: (2021)

Characterization of Klebsiella pneumoniae bacteriophages, KP1 and KP12, with deep learning-based structure prediction
por: Kim, Youngju, et al.
Publicado: (2023)

Interaction with Ribosomal Proteins Accompanies Stress Induction of the Anticancer Metallodrug BOLD‐100/KP1339 in the Endoplasmic Reticulum
por: Neuditschko, Benjamin, et al.
Publicado: (2021)

The serotonin 1A receptor C(-1019)G polymorphism in relation to suicide attempt
por: Wasserman, Danuta, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_38obavco66bpmi30irlbqsp789